Expertise in
14
conditions

Dr. Babak Tousi

Neurology
Office
1450 Belle Ave, 
Lakewood, OH 
Accepting New Patients
Offers Telehealth
Expertise in
14
conditions
Office
1450 Belle Ave, 
Lakewood, OH 

Overview

Babak Tousi is a Neurologist practicing medicine in Lakewood, Ohio.

Dr. Tousi is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Lewy Body Dementia (LBD), Alzheimer's Disease, Cerebellar Degeneration, and Memory Loss.

He is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 5 clinical trials. Dr. Tousi is currently accepting new patients.

Specialties

Neurology

Licenses

Geriatric Medicine in OH

Hospital Affiliations

Akron General Medical Center
Cleveland Clinic Avon Hospital
Cleveland Clinic
Fairview Hospital
Hillcrest Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
SummaCare
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Office
1450 Belle Ave, Lakewood, OH 44107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
Enrollment Status: Completed
Publish Date: June 27, 2024
A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)
A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Drug: Neflamapimod
Study Phase: Phase 2
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: BIIB092
Study Phase: Phase 2
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

26 Total Publications

CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression.
CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression.
Journal: Neurology
Published: November 17, 2025
Similar Doctors
Expertise in
44
conditions
Expertise in
44
conditions
Referral may be required
Before you request

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (9.1 miles away)
216-444-2200
Languages Spoken:
English, Filipino
See accepted insurances
Accepting New Patients
Offers Telehealth

Hubert Fernandez is a Neurologist practicing medicine in Cleveland, Ohio. Dr. Fernandez is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Tardive Dyskinesia, Deep Brain Stimulation, and Gastric Bypass. Dr. Fernandez is board certified in American Board Of Psychiatry And Neurology, 2009. Dr. Fernandez is currently accepting new patients.

Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required
Before you request

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (9.1 miles away)
216-444-2200
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Lara Jehi is a Neurologist practicing medicine in Cleveland, Ohio. Dr. Jehi is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Partial Familial Epilepsy, and Deep Brain Stimulation. Dr. Jehi is board certified in American Board Of Psychiatry And Neurology, 2016. Dr. Jehi is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required
Before you request

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (9.1 miles away)
216-444-2200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nancy Foldvary-Schaefer is a Neurologist practicing medicine in Cleveland, Ohio. Dr. Foldvary-Schaefer is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Narcolepsy, Obstructive Sleep Apnea, Idiopathic Hypersomnia, and Excessive Daytime Sleepiness. Dr. Foldvary-Schaefer is board certified in American Board Of Psychiatry And Neurology, 2013. Dr. Foldvary-Schaefer is currently accepting new patients.

Frequently Asked Questions about Dr. Babak Tousi

How do I make an appointment with Dr. Babak Tousi?

You can book an appointment with Dr. Babak Tousi by calling their office at 216-521-2228. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Babak Tousi a top-rated expert for Lewy Body Dementia (LBD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Babak Tousi is classified as an Distinguished expert for Lewy Body Dementia (LBD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Babak Tousi specialize in?

While Dr. Babak Tousi is a Neurology, they have specific expertise in Lewy Body Dementia (LBD), Alzheimer's Disease, and Cerebellar Degeneration. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Babak Tousi participate in research or clinical trials?

Yes. Dr. Babak Tousi has published 26 articles and abstracts on conditions like Lewy Body Dementia (LBD). You can view a list of Dr. Babak Tousi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Babak Tousi accept my insurance?

Dr. Babak Tousi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 216-521-2228 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tousi's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile